79 new drugs are being added to the Manitoba Pharmacare Program.
Some of the drugs include Revestive for the treatment of short bowel syndrome, Spinraza for Type 1 spinal muscular atrophy, Dysport Therapeutic for the treatment of lower limb spasticity, and Lancora for the treatment of heart failure.
73 are generic medications at different strengths.
Seniors and Active Living Minister Cameron Friesen says the generic reduces the amount that would have otherwise been spent on higher-cost equivalent drugs by $350,000 annually, allowing that money to be reallocated to cover new drugs.
“Medications are important treatments for many different illnesses and diseases,” said Friesen. “Manitoba’s universal prescription drug benefit program is one of the most comprehensive in the country and these new additions will help families across the province access drug coverage through the program.”
Coverage of the new drugs will go into effect on the 24th of January.
For more information on the Manitoba Pharmacare Program, visit:
